uniQure
QURE
#4209
Rank
$2.93 B
Marketcap
$42.63
Share price
-4.16%
Change (1 day)
186.49%
Change (1 year)

P/E ratio for uniQure (QURE)

P/E ratio as of July 2026 (TTM): -11.4

According to uniQure's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -11.4318. At the end of 2025 the company had a P/E ratio of -6.87.

P/E ratio history for uniQure from 2014 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-6.8796.37%
2024-3.50234.49%
2023-1.05-87.49%
2022-8.37-387.39%
20212.91-122.01%
2020-13.2-42.66%
2019-23.189.14%
2018-12.285.47%
2017-6.57243.95%
2016-1.91-58%
2015-4.55-22.74%
2014-5.89

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Amgen
AMGN
25.0-318.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
17.0-248.80%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-0.1682-98.53%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-0.2003-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
42.4-470.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-17.4 52.39%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.